The 510(k) pathway sounds straightforward on paper: demonstrate substantial equivalence to a predicate, submit your documentation, get cleared. In practice, the biocompatibility section alone can generate multiple deficiency rounds if it's not built correctly from the start. That's where a medical device consulting firm comes in. Not as a rubber stamp, and not as someone who fills out forms. A firm with deep regulatory and toxicological expertise shapes the strategy behind yo

Bringing a medical device to the U.S. market means more than selecting a regulatory pathway. Your specific role shapes how you plan, generate, and defend biocompatibility and toxicological data within the FDA framework. Understanding Your Role in the Medical Device Approval Process Medical Device Manufacturers Manufacturers need a clear biocompatibility and toxicology strategy that starts at design input. Key challenges include: Translating intended use and contact duration

Medical device biocompatibility evaluation involves two distinct but complementary approaches: chemical characterization and biological testing. Understanding when each is required—and how they work together—is essential for efficient regulatory submissions and comprehensive safety evaluation. Many manufacturers struggle with determining the appropriate balance between these approaches. Over-reliance on biological testing can miss critical chemical safety concerns, while foc

Chemical characterization is a term that encompasses the identification and analysis of extractable and leachable compounds that can...